EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 105 filers reported holding EPIZYME INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $112,000 | +5500.0% | 44,877 | +32656.9% | 0.01% | +800.0% |
| Q1 2020 | $2,000 | -98.1% | 137 | -96.9% | 0.00% | -90.9% |
| Q4 2019 | $107,000 | +94.5% | 4,368 | -19.1% | 0.01% | +120.0% |
| Q3 2019 | $55,000 | -41.5% | 5,402 | -39.3% | 0.01% | -28.6% |
| Q3 2018 | $94,000 | -13.0% | 8,894 | +11.6% | 0.01% | 0.0% |
| Q2 2018 | $108,000 | -2.7% | 7,972 | +27.5% | 0.01% | -30.0% |
| Q1 2018 | $111,000 | +455.0% | 6,254 | +482.9% | 0.01% | +400.0% |
| Q3 2017 | $20,000 | -85.3% | 1,073 | -89.9% | 0.00% | -91.7% |
| Q3 2015 | $136,000 | +13500.0% | 10,648 | +10548.0% | 0.02% | – |
| Q1 2015 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |